Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 201 of 6351
-
Hong kong study to test CT screening for lung cancer in 15,000 heavy smokers
Diagnosis Not yet recruitingThe investigators propose a randomized controlled trial to evaluate the clinical effectiveness of low-dose computed tomography (LDCT) for lung cancer screening in high-risk Chinese ever-smokers aged 50-79 years in Hong Kong and to assess the cost-effectiveness of implementing LDC…
Sponsor: The University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
Blood test could guide cancer treatment, reducing side effects
Disease control Not yet recruitingThe purpose of this study is to assess risk for HPV driven oropharyngeal cancers by using HPV blood tests and clinical features (such as tumor stage and smoking status) to determine appropriate treatment to improve survival outcomes in participants with stage I, II, or III, HPV-a…
Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
AI could spot hidden cancers on routine CT scans
Diagnosis Not yet recruitingThis study aims to develop and validate a deep learning-based opportunistic multi-cancer screening system using routine non-contrast chest-abdomen-pelvis CT examinations, including CHANCE-Breast, CHANCE-Liver, CHANCE-Kidney, and CHANCE-Bladder, for the early detection of breast, …
Sponsor: Lian Yang • Aim: Diagnosis
Last updated Aug 02, 2026 00:00 UTC
-
New pastille could change head and neck cancer treatment
Disease control Not yet recruitingThis Phase 3, multicenter, randomized, open-label study evaluates APG-157 in adults with newly diagnosed locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Two independently powered cohorts are enrolled based on treatment pathway. Cohort A evaluates APG-157 admini…
Phase 3 • Sponsor: Aveta Biomics, Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Triple attack on liver cancer: blocking blood flow plus immune boost shows promise
Disease control Recruiting nowThe safety, clinical efficacy and prognostic factors of transcatheter arterial chemoembolization (TACE) and/or hepatic artery infusion chemotherapy (HAIC) combined with targeted immunotherapy for primary hepatocellular carcinoma (HCC) require further in-depth study. This research…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Drug duo takes on rare head and neck tumors
Disease control Recruiting nowThis is a prospective, multicenter, multi-cohort, Phase II clinical trial enrolling patients with unresectable, recurrent, or metastatic soft tissue sarcoma, malignant melanoma, adenoid cystic carcinoma, or salivary gland malignancies (excluding adenoid cystic carcinoma) who have…
Phase 1/2 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug combo aims to boost chemo for rare blood cancer
Disease control Not yet recruitingThe goal of this clinical study is to find the best way to combine the study drug BEBT-908 (ifupinostat hydrochloride for injection) with CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) for treating previously untreated peripheral T-cell lymphoma, and to find ou…
Phase 2 • Sponsor: BeBetter Med Inc • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Targeted antibody combo aims to shrink HER2-Positive stomach cancers before surgery
Disease control Not yet recruitingThis is a phase II open-label study to evaluate the efficacy and safety of zanidatamab combined with chemotherapy as neoadjuvant/conversion therapy in patients with HER2-positive (IHC 3+ or IHC 2+) locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma. T…
Phase 2 • Sponsor: Zhifeng Zhao, PhD • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New blood tests aim to catch ovarian cancer earlier
Diagnosis Not yet recruitingOvarian cancer is often diagnosed at a later stage because early symptoms can be mild or non-specific. Earlier detection of ovarian cancer could improve treatment options and outcomes. Recent research has focused on the development of blood-based tests, sometimes referred to as …
Sponsor: National and Kapodistrian University of Athens • Aim: Diagnosis
Last updated Jul 11, 2026 00:00 UTC
-
Could a smart combo of drugs and radiation help some esophageal cancer patients skip surgery?
Disease control OngoingThis multicenter, prospective Phase II study investigates a response-adapted organ-preservation strategy in patients with resectable esophageal squamous cell carcinoma (ESCC). Participants will receive two cycles of induction chemoimmunotherapy with sugemalimab, nab-paclitaxel, a…
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a gentler steroid dose protect children's kidneys without the harsh side effects?
Disease control Recruiting nowChildhood-onset systemic lupus erythematosus (cSLE) is a severe chronic autoimmune disease with a high burden of major-organ involvement. Lupus nephritis (LN) affects more than half of children with SLE, and proliferative LN-including class III, IV, III+V, and IV+V disease-is ass…
Phase 4 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Blood test may take the guesswork out of transplant drug dosing
Disease control Not yet recruitingIMPAKT is a research study that looks at whether a blood test called Prospera™ can help doctors better adjust anti-rejection medications, compared to the usual way doctors manage these medications without using this test.
Sponsor: Natera, Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
AI showdown: three computer models battle to predict lung cancer from CT scans
Diagnosis Not yet recruitingThis multicenter prospective diagnostic accuracy study will compare the performance of three artificial intelligence (AI) models (MVCS, LungDoc, and a United Imaging AI model) for predicting the malignancy risk of pulmonary nodules on chest CT. All enrolled patients will have pul…
Sponsor: Guangdong Provincial People's Hospital • Aim: Diagnosis
Last updated Jul 29, 2026 00:00 UTC
-
Ovarian suppression plus tamoxifen: a Long-Term bet against breast cancer recurrence
Disease control Not yet recruitingThis study evaluates the long-term effects of adding 2 years of ovarian function suppression (OFS) to tamoxifen therapy in young premenopausal women with hormone receptor-positive breast cancer after chemotherapy. The study will assess recurrence, breast cancer-specific survival,…
Sponsor: MedicalExcellence • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Targeted IDH1 inhibitor takes on advanced solid tumors
Disease control Not yet recruitingThis is a multicenter phase II study designed to evaluate the efficacy and safety of TQB3454 as monotherapy in patients with advanced solid tumors, divided into three cohorts.Cohort 1: Enrolled patients with diffuse glioma harbouring IDH1 R132 mutations. Cohort 2: Enrolled patien…
Phase 2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Robots vs. surgeons: a precision showdown for thigh fractures
Disease control Recruiting nowThis study aims to evaluate the clinical efficacy and safety of an intelligent robotic system for the closed reduction of extra-articular supracondylar femoral fractures (Arbeitsgemeinschaft für Osteosynthesefragen/Orthopaedic Trauma Association AO/OTA 33-A). Traditional manual r…
Sponsor: Beijing Jishuitan Hospital • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Smart earbuds that listen to your heart could lull you to sleep
Symptom relief OngoingThis study evaluates a new smart sleep earbud designed to help adults suffering from chronic insomnia. The device uses artificial intelligence (AI) to track a user's real-time heart rate and movement through the ear canal, automatically adjusting soothing music parameters to help…
Sponsor: The Chinese University of Hong Kong, Shenzhen • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Can rewiring fear expectations stop anxiety from coming back?
Symptom relief Recruiting nowThis clinical trial evaluates whether an optimized exposure-based treatment improves long-term outcomes for adults with anxiety disorders. Specifically, it examines whether Expectancy Focused Exposure (EFE), based on the inhibitory learning model, is more effective than Anxiety F…
Sponsor: University of Chile • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
Can a new formula save more children from severe malnutrition?
Disease control By invitation onlyThe current WHO-recommended F-75 diet for stabilization of SAM has remained largely unchanged since its development in the 1990s. No clinical trial has studied enhanced therapeutic formulas during the stabilization phase, particularly in high-burden, low-resource settings. Additi…
Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Can an antibody boost chemotherapy to stop early stomach cancer from returning?
Disease control Recruiting nowThis study employs a multicenter randomized controlled trial design, led by the First Affiliated Hospital of Air Force Medical University (Xijing Hospital) in collaboration with 10 other domestic medical institutions, for a total of 11 research centers. The study plans to enroll …
Phase 2 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC